Starbucks (SBUX) Offering Possible 17.1% Return Over the Next 10 Calendar Days

Starbucks's most recent trend suggests a bearish bias. One trading opportunity on Starbucks is a Bear Call Spread using a strike $87.50 short call and a strike $92.50 long call offers a potential 17.1% return on risk over the next 10 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $87.50 by expiration. The full premium credit of $0.73 would be kept by the premium seller. The risk of $4.27 would be incurred if the stock rose above the $92.50 long call strike price.

The 5-day moving average is moving up which suggests that the short-term momentum for Starbucks is bullish and the probability of a rise in share price is higher if the stock starts trending.

The 20-day moving average is moving down which suggests that the medium-term momentum for Starbucks is bearish.

The RSI indicator is at 29.17 level which suggests that the stock is neither overbought nor oversold at this time.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here


LATEST NEWS for Starbucks

Dunkin’s average ticket nearly doubles when customers add Beyond Meat sandwich
Sat, 08 Feb 2020 16:50:00 +0000
Dunkin’ says the average ticket with a Beyond Sausage is more than $9 while the average ticket is about $5.

7 U.S. Stocks to Buy on Coronavirus Weakness
Fri, 07 Feb 2020 19:56:12 +0000
The outbreak of China's coronavirus is a big deal. To date, it has infected over 30,000 people across the globe, and killed at least 638. Even if the disease stopped spreading today — which it won't — this outbreak will still go down as one of the most pervasive epidemics in modern world history.And yet, markets don't seem to care. U.S. stocks dropped big on Friday, Jan. 31, on coronavirus concerns. And that was it. Ever since, stocks have been in rally mode, with the S&P 500 cruising to fresh all-time highs in early February.Why? Because, while the coronavirus outbreak is a big deal, it's also a short-term deal. Outbreaks happen all the time. They never last more than a few months. They hit, they spread, they peak, they go down and within a few months, they're gone. Their impact on the economy, while severe for a few months, is short-lived, and economic activity always rebounds sharply as soon as the virus disappears.InvestorPlace – Stock Market News, Stock Advice & Trading TipsIt also helps that: 1) the Wuhan coronavirus isn't as deadly as other viruses with a mere 2% fatality rate (SARS, by comparison, had a 10% fatality rate), 2) it's largely contained to China, 3) significant progress has been made on a potential treatment or cure, and 4) in response to the virus outbreak, China has injected tons of fiscal stimuli and halved tariffs on U.S. goods.As such, when it comes to the coronavirus, you have a short-term problem. The best investment game-plan is to buy the short-term weakness in long-term winners. * 7 Utility Stocks to Buy That Offer Juicy Dividends I already picked some Chinese stocks to buy once coronavirus fears fade. Now, I'm picking seven U.S. stocks to buy on coronavirus weakness.Without further ado, let's take a look at those names. Stocks to Buy: Apple (AAPL)Source: View Apart / Shutterstock.com Global technology giant Apple (NASDAQ:AAPL) has been hit hard from multiple angles thanks to the coronavirus outbreak in China. First, the company closed all corporate offices, stores and contact centers in mainland China until Feb. 9. Second, many of Apple's suppliers have been ordered to reduce or altogether halt production until Feb. 10. Third, thanks to the production pause, Apple's AirPods may have a supply shortage for the new few weeks.None of that is great news, especially since China is a big part of the Apple growth narrative. As such, it should be no surprise that Apple stock dropped 5% Jan. 31 on coronavirus fears.But, Apple will be just fine. This is true for a few reasons. First, the App Store will get a big boost during the outbreak (there are hundreds of millions of Chinese consumers stuck at home, desperate for ways to entertain themselves). Second, February typically isn't a big month for iPhone sales. Third, because an iPhone is a big-ticket purchase, any lost demand during February won't forever disappear — it will just shift into March or April. Fourth, Apple's big iPhone launch comes in the back half of 2020. By then, the outbreak should be old news.All in all, Apple will weather the coronavirus storm just fine, and the company is still staring at huge growth potential in the back half of the year. Nike (NKE)Source: Square Box Photos / Shutterstock.com Shares of global athletic apparel giant Nike (NYSE:NKE) dropped about 8% in late January on concerns that the coronavirus outbreak could materially impact the company's operations in China.Those concerns were confirmed in early February, when management said in a press release that they expect the outbreak to have a "material impact" on operations in China. The company said it has shut down about half of its stores in China. Those that remain open are operating at reduced hours with lower-than-usual traffic volumes.That's not great news for Nike. A slowdown in this big and hyper-growth segment will have ripple effects across Nike's entire business. * 7 Large-Cap Stocks to Buy For Insulation From Volatility But, this negative impact will be short-lived. During the SARS epidemic, retail sales in China slowed during the outbreak, but as soon as the outbreak cleared up, retail sales trends came roaring back to life in a hurry. The same thing should happen this time around, especially since the People's Bank of China (PBOC) has injected stimulus packages and tariffs on U.S. goods have been halved. Thus, once the outbreak ends, retail sales in China will accelerate meaningfully, and Nike's China business will get back to firing on all cylinders. Advanced Micro Devices (AMD)Source: Joseph GTK / Shutterstock.com In the last week of January, shares of red-hot chip maker Advanced Micro Devices (NASDAQ:AMD) dropped about 10% amid concerns that the coronavirus outbreak would dampen chip demand in China. To make matters worse, AMD reported mixed fourth-quarter numbers in late January that included a light first-quarter revenue guide.But, these concerns seem overstated.As I've written before, global epidemics historically tend not to have an impact on the semiconductor market. SARS didn't hit the semiconductor market in 2002. On the contrary, global semiconductor sales actually rose during the SARS outbreak. Similarly, during the H7N9 outbreak in the 2010s, global semiconductor sales rose.The same thing should happen this time, especially since U.S-China trade tensions are easing while central banks through Asia are rushing to inject stimulus packages and support their economies. Once this outbreak ends, corporate spending on things like semiconductor chips should roar higher. AMD's numbers will charge even higher, since this company remains the market share leader in critical verticals of the semiconductor market.Big picture — coronavirus weakness in AMD stock is overstated. Over the next few months, the fundamentals underlying AMD will improve, not deteriorate. As they do, AMD stock will go higher, not lower. Starbucks (SBUX)Source: Grand Warszawski / Shutterstock.com Much like Nike, global coffee house operator Starbucks (NASDAQ:SBUX) has been forced to close about half of its cafes in China, with an unclear timeline as to when those stores will re-open. Also, echoing what management at Nike said, Starbucks management said that they expect the outbreak to have a "materially" negative impact on current quarter and full-year numbers.In response to that news, Starbucks stock has shed about 10% off its mid-January highs.But, while China remains a very important piece of the Starbucks growth narrative, the country accounts for only about 10% of Starbucks' total revenue. So, the negative impacts won't be that big. Further, they will be ephemeral. They won't have any impact on the long-term growth narrative, which is centered around increasing coffee consumption, urbanization and a rising middle class in China.If anything, tons of fiscal stimulus from the PBOC will only accelerate those longer-term trends once the outbreak passes. * 7 Stocks to Buy for February Contrarians As such, if Starbucks stock keeps dropping on coronavirus fears, that weakness will ultimately be nothing more than a good buying opportunity into a long-term winner. Intel (INTC)Source: JHVEPhoto / Shutterstock.com The bull thesis on global semiconductor giant Intel (NASDAQ:INTC) is very similar to the bull thesis on Advanced Micro Devices.Specifically, Intel stock dropped about 8% in late January on fears that the coronavirus outbreak in China would dampen global semiconductor demand. But, historically speaking, Chinese-originated global epidemics don't have a meaningful impact on global semiconductor demand. On the contrary, global semiconductor sales rose in 2002-03 amid the SARS outbreak, and in the 2010s amid the H7N9 outbreak.Meanwhile, Intel just reported a blowout fourth-quarter earnings report and delivered a robust first-quarter guide, the sum of which imply that demand in the company's core data-centric markets is rebounding, not falling.It will take more than a short-term epidemic in China to derail these rebounding demand trends. Plus, once the epidemic fades, these data-centric demand trends will actually accelerate higher, because of stimulus from Asian central banks as well as accelerated U.S.-China trade war deescalation.Broadly, then, the most likely path forward for Intel stock in 2020 is higher, not lower. Skechers (SKX)Source: ThamKC / Shutterstock.com Very similar to Nike, global athletic apparel company Skechers (NYSE:SKX) has broad exposure to China, and as such, Skechers stock dropped on fears that the coronavirus outbreak could provide a meaningful drag on the company's numbers. But in mid-day trading, SKX stock is up over 5% on record sales figures.To give you an idea of how important China is to Skechers, the word "China" was used over 50 times in the company's most recent conference call, versus less than 20 combined mentions of "U.S." and the "United States." That's because Skechers opened 87 new stores in China in the third quarter, is constructing its first distribution center in China, and reported 21% constant-currency sales growth in the country in Q3.In other words, China is really important to the Skechers growth narrative.But the coronavirus outbreak isn't here to stay. It will disappear, and probably fairly soon, considering that the spread rate of the disease has dropped dramatically in recent days. Once it clears up, consumers will rush back to their old ways, and retail sales trends will rebound significantly (just look at how retail sales trends in China rebounded as soon as the SARS outbreak ended). * 7 Under-the-Radar European Stocks to Buy for 2020 Consequently, Skechers' numbers may be bad for a month or two. And that's it. Meanwhile, Skechers stock is still very cheap at just 14 times forward earnings. That's too cheap to not buy the stock on an overdone selloff. Crocs (CROX)Source: Wannee_photographer / Shutterstock.com Staying in the retail world, sandal maker Crocs (NASDAQ:CROX) has dropped 11% amid the Wuhan coronavirus outbreak. While this selloff may not have everything to do with the epidemic, it is nonetheless overdone given the operational momentum Crocs has today, and the limited exposure the brand has to China.Crocs operates 146 stores in all of Asia, and only a handful of those are in China (only 28 as of December 2018). In total, Crocs operates about 368 stores in the world. So, Crocs has limited exposure to Asia (only 40% store exposure, which is less than many other global apparel brands) and extremely mitigated exposure to China (only 8% store exposure). This limited exposure means that Crocs numbers likely won't be hit all that hard by the coronavirus outbreak.At the same time, this brand is on fire right now. The company just reported its best ever fourth quarter. Revenues, margins and profits are roaring higher as Crocs are regaining mainstream fashion relevance and popularity amid a return to "ugly shoe" styles. This trend is showing no signs of easing. So, big growth should continue here for the foreseeable future.As it does, Crocs stock will bounce back from this recent selloff. Estee Lauder (EL)Source: Ken Wolter / Shutterstock.com One of the companies hit hardest by the coronavirus outbreak in China has been multinational beauty care giant Estee Lauder (NYSE:EL), who derives a whopping 17% of its sales from China.Thanks to the broad exposure, Credit Suisse estimates that Estee Lauder could see 3% to 5% decrease in earnings per share this quarter. This profit risk is why Estee Lauder stock dropped more than 10% in the wake of the coronavirus outbreak.But, Estee Lauder just reported fourth-quarter numbers. They were quite good, beating on both the top and bottom lines. And, while management said that retail store closures, reduced retail hours, lower store traffic volumes and travel restrictions will weigh on near-term operating results, management also sounded confident in their ability to weather the storm and mitigate adverse impacts.Specifically, instead of running away from China, Estee Lauder is doubling down on China. It is going to up research and development spending. It is going to build a new innovation center, launch new fragrance products this year and continue to build-out the online channel.Management's confident tone breathed life back into bulls. Estee Lauder stock rallied after the print. And, it appears that so long as the coronavirus outbreak doesn't get worse from here, this stock is on course to rebound over the next few months.As of this writing, Luke Lango was long AAPL. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Utility Stocks to Buy That Offer Juicy Dividends * 10 Gold and Silver Stocks to Profit Off 2020's Fear Trade * 3 Top Companies That Should Be More Careful With Your Data The post 7 U.S. Stocks to Buy on Coronavirus Weakness appeared first on InvestorPlace.

3 Things to Know About the Q4 Earnings Season
Fri, 07 Feb 2020 19:55:07 +0000
3 Things to Know About the Q4 Earnings Season

Recent Panic Creates Long-Term Opportunity in China’s Luckin Coffee
Fri, 07 Feb 2020 15:18:41 +0000
Only two questions really matter for Luckin Coffee (NASDAQ:LK). Can Luckin outgrow Starbucks (NASDAQ:SBUX) in China? If so, what is LK stock worth in that bullish scenario? Everything else is just noise.Source: Keitma / Shutterstock.com Luckin has dealt with a lot of noise of late. The spread of the coronavirus in China has led to store closures which will dent the company's sales and profits for at least the first quarter of 2020. A short-seller report drove panic selling as well.But investors shouldn't focus on short-term issues at the expense of the long-term trend. The trend promises potentially enormous returns for Luckin Coffee shareholders. All those issues have done is create a more attractive entry point.InvestorPlace – Stock Market News, Stock Advice & Trading Tips Luckin Coffee Soars — And TumblesJust a few weeks ago, LK stock was one of the market's best performers. Thanks in part to a blowout third-quarter earnings report in November, shares rose almost 200% in a little over two months.Two developments ended the rally. Coronavirus fears rattled global stocks, and took LK down with them. * 7 Utility Stocks to Buy That Offer Juicy Dividends To add to the panic, Muddy Waters Research, via Twitter (NYSE:TWTR), linked to an anonymous report alleging that Luckin had fraudulently inflated its numbers. The 89-page report claimed to rest on video of 620 Luckin stores across China. Those tests suggested that the number of items sold per day was overstated by 69% in the third quarter of 2019. The report alleged pricing inflation as well.LK stock plunged over 10% that day, capping a 35% decline in just nine trading sessions. Short-Term FearsThe problem with the selloff is that neither issue changes the long-term case for Luckin.Luckin is going toe-to-toe with Starbucks in the world's most populated country — and winning. Luckin now has more stores in the country than does Starbucks. It's growing faster than its U.S. rival. And its model of often-unmanned stores and app-focused checkout procedures both suggest operating profit margins at maturity should be quite attractive.The long-term opportunity here is why investors bid Luckin up so sharply after the third-quarter report. Early results show that Luckin is succeeding in shifting Chinese customers away from tea to coffee — and keeping those customers away from Starbucks. The company has plans to add thousands more stores to attract hundreds of millions more customers. And thanks to a convertible bond and stock offering last month, it has the capital to do so.Neither piece of short-term news impacts that long-term bull case. The spread of the coronavirus will be contained at some point. The short-seller report looks questionable.In fact, Citron Research, well-known for shorting the likes of Shopify (NYSE:SHOP) and Bausch Health (NYSE:BHC), has said it is long LK stock. The report "will fall short on accuracy," Citron wrote last week. The firm added that it expected Luckin's management to respond.Management did respond this week, and flatly denied the report. Investors listened. Luckin stock soared 15.6% in trading on Tuesday. The Long-Term Case for LK StockThat rally should continue as the short-term fears fade. From a long-term standpoint, LK stock still looks reasonably cheap.Admittedly, the company isn't profitable. But that's no surprise. Upfront spending to acquire new customers and to build out new stores is leading to near-term losses. But there's a clear path for Luckin to grow into a nicely profitable business. As long as that path continues, LK stock can rise as have so many other growth stocks in this market.Looking at revenue, the stock already doesn't appear that expensive. Luckin stock trades for a little over 5x Wall Street's estimate for 2020 sales. SBUX trades for roughly 4x revenue. Surely, investors should pay a modest premium for a substantially greater growth opportunity. Starbucks' core markets in the U.S. and Europe are largely saturated. Luckin has no such problem in China.As long as Luckin's opportunity remains intact, and the company executes, LK stock can keep gaining. The noise that drove recent volatility is meaningless in that context. Some investors took the selloff as a buying opportunity on Tuesday. I expect more will do so going forward.Matthew McCall left Wall Street to actually help investors — by getting them into the world's biggest, most revolutionary trends BEFORE anyone else. The power of being "first" gave Matt's readers the chance to bank +2,438% in Stamps.com (STMP), +1,523% in Ulta Beauty (ULTA) and +1,044% in Tesla (TSLA), just to name a few. Click here to see what Matt has up his sleeve now. Matt does not directly own the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Utility Stocks to Buy That Offer Juicy Dividends * 10 Gold and Silver Stocks to Profit Off 2020's Fear Trade * 3 Top Companies That Should Be More Careful With Your Data The post Recent Panic Creates Long-Term Opportunity in China's Luckin Coffee appeared first on InvestorPlace.

Editor's picks: Five things to know while you decide whether or not to check out the XFL
Fri, 07 Feb 2020 10:00:00 +0000
Starbucks will expand its community stores initiative — which began in 2015 with 14 locations — to 100 stores by 2025.

Related Posts

 

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.